FLUOXETINE HYDROCHLORIDE

FLUOXETINE HYDROCHLORIDE was reported 128596 times

FLUOXETINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTIDEPRESSANT DRUG LEVEL INCREASED 91 0.2563
1 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 172 0.2489
2 AMAUROSIS FUGAX 232 0.2154
3 PERSISTENT FOETAL CIRCULATION 92 0.1508
4 DISINHIBITION 227 0.1409
5 SEROTONIN SYNDROME 2409 0.1253
6 AUTISM 118 0.1161
7 PHYSICAL DECONDITIONING 298 0.1157
8 CONGENITAL CARDIOVASCULAR ANOMALY 97 0.1156
9 CRANIOSYNOSTOSIS 96 0.1109
10 TALIPES 266 0.0856
11 BEZOAR 118 0.0855
12 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 165 0.0835
13 MAJOR DEPRESSION 594 0.0812
14 OBSESSIVE-COMPULSIVE DISORDER 602 0.0749
15 HOMICIDE 127 0.0689
16 ANORGASMIA 180 0.0662
17 SUICIDAL BEHAVIOUR 268 0.0644
18 HYPERREFLEXIA 214 0.0614
19 FLAT AFFECT 142 0.0613
20 CLEFT PALATE 118 0.0610
21 CLONUS 166 0.0606
22 ANTIPSYCHOTIC DRUG LEVEL INCREASED 169 0.0600
23 OCULOGYRIC CRISIS 128 0.0596
24 SELF-INJURIOUS IDEATION 231 0.0550
25 INTENTIONAL SELF-INJURY 1100 0.0544
26 TEARFULNESS 228 0.0530
27 URINARY TRACT DISORDER 236 0.0524
28 VENTRICULAR SEPTAL DEFECT 295 0.0515
29 AKATHISIA 699 0.0512
30 DEREALISATION 107 0.0497
31 GAMBLING DISORDER 134 0.0496
32 ATRIAL SEPTAL DEFECT 412 0.0491
33 INTENTIONAL OVERDOSE 3114 0.0485
34 HOSTILITY 123 0.0483
35 TORSADE DE POINTES 378 0.0481
36 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 246 0.0479
37 PHYSICAL ASSAULT 100 0.0478
38 SUICIDE ATTEMPT 2894 0.0477
39 IMPULSIVE BEHAVIOUR 178 0.0474
40 HOMICIDAL IDEATION 184 0.0453
41 BIPOLAR I DISORDER 99 0.0451
42 PATENT DUCTUS ARTERIOSUS 178 0.0448
43 COMPLETED SUICIDE 3708 0.0445
44 LIBIDO INCREASED 90 0.0443
45 THERAPEUTIC PRODUCT EFFECT VARIABLE 171 0.0440
46 SUSPECTED SUICIDE 205 0.0437
47 EXPOSURE DURING BREAST FEEDING 144 0.0434
48 BRADYPNOEA 117 0.0433
49 NEONATAL RESPIRATORY DISTRESS SYNDROME 153 0.0432
50 HAEMORRHAGIC STROKE 334 0.0427
51 PERSONALITY DISORDER 112 0.0427
52 DEPRESSIVE SYMPTOM 149 0.0422
53 WHITE BLOOD CELL COUNT ABNORMAL 267 0.0418
54 OBESITY 656 0.0411
55 SUICIDAL IDEATION 3761 0.0410
56 POISONING DELIBERATE 386 0.0407
57 SOCIAL AVOIDANT BEHAVIOUR 232 0.0401
58 SEXUAL DYSFUNCTION 467 0.0398
59 REBOUND ACID HYPERSECRETION 120 0.0396
60 NEPHROGENIC ANAEMIA 183 0.0395
61 NEGATIVE THOUGHTS 114 0.0389
62 HYPOMANIA 143 0.0388
63 TACHYPHRENIA 134 0.0387
64 COMA SCALE ABNORMAL 112 0.0386
65 MANIA 633 0.0384
66 ALCOHOL POISONING 103 0.0384
67 ELECTROCARDIOGRAM QT PROLONGED 1383 0.0384
68 DIABETIC NEUROPATHY 189 0.0381
69 ANXIETY DISORDER 127 0.0380
70 EUPHORIC MOOD 389 0.0379
71 BRUXISM 204 0.0378
72 TIC 206 0.0377
73 MULTIPLE DRUG OVERDOSE INTENTIONAL 120 0.0373
74 HYPERPARATHYROIDISM SECONDARY 92 0.0367
75 FEELING OF DESPAIR 166 0.0356
76 RESPIRATORY DEPRESSION 434 0.0354
77 POISONING 443 0.0352
78 DECREASED INTEREST 206 0.0349
79 BIPOLAR DISORDER 372 0.0342
80 CATATONIA 179 0.0341
81 DYSLIPIDAEMIA 172 0.0338
82 AUTONOMIC NERVOUS SYSTEM IMBALANCE 97 0.0332
83 DISSOCIATION 253 0.0330
84 MULTIPLE DRUG OVERDOSE 163 0.0328
85 HEART DISEASE CONGENITAL 114 0.0322
86 ELECTRIC SHOCK SENSATION 90 0.0321
87 CHOLECYSTITIS CHRONIC 214 0.0319
88 LOSS OF LIBIDO 287 0.0319
89 HALLUCINATION, AUDITORY 506 0.0318
90 DRUG INTERACTION 4995 0.0315
91 PRIAPISM 108 0.0313
92 PRE-EXISTING CONDITION IMPROVED 195 0.0312
93 APATHY 454 0.0311
94 ALCOHOL USE 113 0.0306
95 PARANOIA 523 0.0303
96 GESTATIONAL DIABETES 144 0.0302
97 SMALL FOR DATES BABY 150 0.0302
98 RESTLESS LEGS SYNDROME 542 0.0298
99 DEPRESSION SUICIDAL 103 0.0297
100 AFFECTIVE DISORDER 233 0.0296
101 SOMNAMBULISM 192 0.0292
102 SEDATION 766 0.0292
103 PANIC REACTION 210 0.0291
104 ATRIOVENTRICULAR BLOCK FIRST DEGREE 126 0.0290
105 FOETAL EXPOSURE DURING PREGNANCY 2355 0.0289
106 SINUS BRADYCARDIA 280 0.0289
107 MYOCLONUS 344 0.0288
108 PANIC ATTACK 1046 0.0287
109 POST-TRAUMATIC STRESS DISORDER 192 0.0286
110 GENERALISED TONIC-CLONIC SEIZURE 473 0.0286
111 MUSCLE TWITCHING 658 0.0285
112 ENURESIS 115 0.0284
113 MUSCLE RIGIDITY 340 0.0284
114 MYDRIASIS 361 0.0281
115 AGITATION 2064 0.0281
116 HALLUCINATIONS, MIXED 118 0.0280
117 SNORING 106 0.0280
118 ALCOHOLISM 120 0.0280
119 BRADYPHRENIA 181 0.0277
120 CARDIO-RESPIRATORY ARREST 1158 0.0277
121 METABOLIC ACIDOSIS 877 0.0274
122 PANIC DISORDER 106 0.0273
123 PRE-ECLAMPSIA 129 0.0271
124 NEUROLEPTIC MALIGNANT SYNDROME 321 0.0270
125 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 112 0.0269
126 APPETITE DISORDER 177 0.0267
127 HYPERTONIA 152 0.0265
128 PREMATURE LABOUR 150 0.0265
129 POTENTIATING DRUG INTERACTION 89 0.0265
130 PARKINSONISM 255 0.0261
131 BLOOD PROLACTIN INCREASED 123 0.0261
132 DEPRESSION 5926 0.0260
133 AGGRESSION 1302 0.0260
134 TOXICITY TO VARIOUS AGENTS 4380 0.0259
135 PERSONALITY CHANGE 241 0.0259
136 SINUS TACHYCARDIA 367 0.0258
137 CARDIAC MURMUR 220 0.0254
138 MATERNAL DRUGS AFFECTING FOETUS 194 0.0253
139 FEELING DRUNK 188 0.0253
140 OCULAR DISCOMFORT 283 0.0252
141 INCREASED APPETITE 480 0.0251
142 COMA 1193 0.0250
143 MIOSIS 201 0.0250
144 LEFT VENTRICULAR HYPERTROPHY 107 0.0250
145 SOPOR 331 0.0250
146 SLEEP APNOEA SYNDROME 476 0.0249
147 HYPERLIPIDAEMIA 296 0.0247
148 DYSPHEMIA 108 0.0246
149 CONCUSSION 190 0.0245
150 NYSTAGMUS 130 0.0245
151 PRODUCT ADMINISTRATION INTERRUPTED 192 0.0244
152 STRESS CARDIOMYOPATHY 142 0.0244
153 DISTURBANCE IN ATTENTION 1309 0.0242
154 THINKING ABNORMAL 452 0.0242
155 DRUG TOXICITY 330 0.0242
156 GENERALISED OEDEMA 299 0.0241
157 DRUG ABUSE 1998 0.0240
158 GALACTORRHOEA 154 0.0240
159 EYE MOVEMENT DISORDER 164 0.0239
160 AUTISM SPECTRUM DISORDER 131 0.0238
161 HEAD DISCOMFORT 421 0.0238
162 DEPRESSED MOOD 1256 0.0237
163 ANGER 797 0.0235
164 BUNDLE BRANCH BLOCK RIGHT 107 0.0233
165 RESTLESSNESS 853 0.0233
166 COMMUNICATION DISORDER 89 0.0232
167 PULSELESS ELECTRICAL ACTIVITY 97 0.0232
168 NIGHTMARE 799 0.0231
169 HYPERPHAGIA 92 0.0230
170 AFFECT LABILITY 221 0.0229
171 CARDIOMEGALY 282 0.0229
172 CRYING 832 0.0229
173 RESPIRATORY ARREST 629 0.0228
174 SPINAL OSTEOARTHRITIS 200 0.0227
175 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 233 0.0227
176 TRICUSPID VALVE INCOMPETENCE 178 0.0224
177 INTERVERTEBRAL DISC DEGENERATION 207 0.0223
178 PHOTOPHOBIA 420 0.0223
179 ALTERED STATE OF CONSCIOUSNESS 481 0.0222
180 IRRITABILITY 1331 0.0221
181 TYPE 1 DIABETES MELLITUS 133 0.0221
182 DRUG EXPOSURE DURING PREGNANCY 745 0.0219
183 WITHDRAWAL SYNDROME 916 0.0218
184 TYPE 2 DIABETES MELLITUS 732 0.0217
185 DYSPHORIA 109 0.0215
186 DYSKINESIA 874 0.0215
187 TRISMUS 111 0.0215
188 ABNORMAL BEHAVIOUR 851 0.0215
189 BLOOD CHOLESTEROL ABNORMAL 99 0.0214
190 TENSION 130 0.0213
191 RESPIRATION ABNORMAL 147 0.0213
192 INITIAL INSOMNIA 217 0.0211
193 DRUG LEVEL INCREASED 349 0.0211
194 HAEMODYNAMIC INSTABILITY 160 0.0210
195 DYSTONIA 406 0.0209
196 POOR QUALITY SLEEP 450 0.0209
197 ATTENTION DEFICIT HYPERACTIVITY DISORDER 88 0.0209
198 HYPERPROLACTINAEMIA 135 0.0208
199 ABNORMAL DREAMS 575 0.0208
200 GRAND MAL CONVULSION 192 0.0208
201 DELUSION 322 0.0207
202 RALES 120 0.0206
203 PSYCHOLOGICAL TRAUMA 178 0.0206
204 MOOD SWINGS 655 0.0205
205 ARTERIOSCLEROSIS CORONARY ARTERY 136 0.0205
206 COORDINATION ABNORMAL 286 0.0205
207 METABOLIC DISORDER 119 0.0205
208 ANXIETY 5826 0.0205
209 PSYCHIATRIC SYMPTOM 151 0.0204
210 DRUG USE DISORDER 172 0.0204
211 TREMOR 3356 0.0202
212 PSYCHOTIC DISORDER 597 0.0202
213 COLITIS MICROSCOPIC 95 0.0200
214 BLOOD MAGNESIUM DECREASED 172 0.0199
215 HYPERSOMNIA 568 0.0198
216 HEPATIC STEATOSIS 368 0.0197
217 BLOOD TRIGLYCERIDES INCREASED 349 0.0197
218 DEPRESSED LEVEL OF CONSCIOUSNESS 781 0.0197
219 FLANK PAIN 185 0.0197
220 FORMICATION 137 0.0197
221 CHRONIC KIDNEY DISEASE 1484 0.0195
222 ECONOMIC PROBLEM 295 0.0194
223 END STAGE RENAL DISEASE 354 0.0194
224 FEAR 521 0.0194
225 FAECAL INCONTINENCE 93 0.0193
226 ANHEDONIA 507 0.0193
227 ENERGY INCREASED 113 0.0191
228 PSYCHOMOTOR HYPERACTIVITY 317 0.0191
229 MENTAL DISORDER 829 0.0190
230 TARDIVE DYSKINESIA 536 0.0190
231 ORTHOSTATIC HYPOTENSION 330 0.0189
232 SCREAMING 119 0.0187
233 HAEMATEMESIS 472 0.0186
234 EXTRAPYRAMIDAL DISORDER 461 0.0185
235 MITRAL VALVE INCOMPETENCE 210 0.0185
236 DRUG ABUSER 114 0.0185
237 ABNORMAL LOSS OF WEIGHT 126 0.0185
238 SWOLLEN TONGUE 573 0.0183
239 PRESYNCOPE 445 0.0183
240 UNRESPONSIVE TO STIMULI 472 0.0183
241 DRUG TOLERANCE 92 0.0182
242 SALIVARY HYPERSECRETION 181 0.0181
243 DIPLOPIA 468 0.0180
244 MOOD ALTERED 490 0.0179
245 GLUCOSE TOLERANCE IMPAIRED 106 0.0179
246 ASPHYXIA 146 0.0179
247 LEFT VENTRICULAR DYSFUNCTION 119 0.0177
248 ACUTE RESPIRATORY DISTRESS SYNDROME 312 0.0176
249 TACHYCARDIA 1556 0.0175
250 VITAMIN D DEFICIENCY 170 0.0174
251 SOMNOLENCE 3504 0.0174
252 HYPONATRAEMIA 977 0.0173
253 PRESCRIBED OVERDOSE 335 0.0173
254 ATELECTASIS 167 0.0173
255 URINARY INCONTINENCE 512 0.0173
256 MICTURITION URGENCY 197 0.0172
257 DENTAL CARIES 190 0.0172
258 HYPERTHERMIA 131 0.0171
259 SCOLIOSIS 106 0.0171
260 FEELING JITTERY 326 0.0171
261 HALLUCINATION, VISUAL 359 0.0170
262 MENTAL STATUS CHANGES 471 0.0169
263 TINNITUS 779 0.0169
264 PREMATURE BABY 510 0.0169
265 OVERWEIGHT 91 0.0169
266 DYSARTHRIA 637 0.0169
267 HIATUS HERNIA 218 0.0168
268 DRUG SCREEN POSITIVE 133 0.0168
269 EATING DISORDER 356 0.0167
270 DIABETES MELLITUS 1274 0.0167
271 BLOOD LACTIC ACID INCREASED 88 0.0167
272 CHOLECYSTECTOMY 190 0.0166
273 AMNESIA 1082 0.0166
274 EMOTIONAL DISORDER 507 0.0164
275 ATAXIA 195 0.0164
276 CEREBRAL DISORDER 121 0.0163
277 DIABETES MELLITUS INADEQUATE CONTROL 288 0.0163
278 CARDIAC ARREST 1329 0.0161
279 BLOOD CHOLESTEROL INCREASED 750 0.0161
280 ANGIOPATHY 90 0.0160
281 PNEUMONIA ASPIRATION 401 0.0160
282 HAIR DISORDER 132 0.0160
283 CONFUSIONAL STATE 2589 0.0160
284 CONGENITAL ANOMALY 124 0.0160
285 DRUG WITHDRAWAL SYNDROME NEONATAL 237 0.0160
286 INSOMNIA 4259 0.0160
287 HYPERHIDROSIS 2055 0.0159
288 ELECTROCARDIOGRAM ABNORMAL 125 0.0159
289 DROOLING 110 0.0159
290 DIVERTICULUM 113 0.0159
291 GASTROOESOPHAGEAL REFLUX DISEASE 1276 0.0158
292 VENTRICULAR FIBRILLATION 176 0.0158
293 HYSTERECTOMY 137 0.0158
294 WEIGHT INCREASED 3536 0.0158
295 SLEEP DISORDER 1109 0.0157
296 LETHARGY 901 0.0156
297 URINARY RETENTION 517 0.0155
298 HYPOTHERMIA 156 0.0154
299 HALLUCINATION 1159 0.0154
300 BRAIN INJURY 154 0.0153
301 HYPERVENTILATION 89 0.0153
302 BALANCE DISORDER 1326 0.0153
303 BLOOD POTASSIUM DECREASED 461 0.0153
304 TOOTH FRACTURE 169 0.0153
305 DISORIENTATION 607 0.0153
306 MENTAL IMPAIRMENT 371 0.0153
307 INCOHERENT 99 0.0153
308 BRADYKINESIA 90 0.0152
309 GALLBLADDER DISORDER 272 0.0152
310 NERVOUSNESS 795 0.0152
311 ACTIVITIES OF DAILY LIVING IMPAIRED 299 0.0151
312 MIDDLE INSOMNIA 281 0.0150
313 RHABDOMYOLYSIS 626 0.0150
314 FIBROMYALGIA 363 0.0149
315 DIZZINESS POSTURAL 143 0.0147
316 DECREASED ACTIVITY 159 0.0147
317 ERECTILE DYSFUNCTION 378 0.0147
318 PULMONARY CONGESTION 194 0.0147
319 TENDERNESS 153 0.0147
320 IMPAIRED GASTRIC EMPTYING 200 0.0147
321 NEUTROPHIL COUNT INCREASED 150 0.0146
322 RIB FRACTURE 301 0.0146
323 HYPERCHOLESTEROLAEMIA 141 0.0146
324 INCONTINENCE 154 0.0146
325 HYPOKALAEMIA 668 0.0145
326 CONVULSION 826 0.0144
327 APNOEA 112 0.0144
328 VENTRICULAR EXTRASYSTOLES 148 0.0142
329 ASPIRATION 156 0.0142
330 OSTEOPENIA 216 0.0142
331 INTERVERTEBRAL DISC PROTRUSION 311 0.0142
332 COGNITIVE DISORDER 664 0.0142
333 LEUKOCYTOSIS 257 0.0142
334 GASTRITIS 373 0.0142
335 SLUGGISHNESS 144 0.0141
336 TONGUE DISORDER 102 0.0141
337 VENTRICULAR TACHYCARDIA 232 0.0140
338 MEMORY IMPAIRMENT 1930 0.0140
339 LACERATION 132 0.0140
340 BRADYCARDIA 744 0.0140
341 SPEECH DISORDER 732 0.0140
342 SENSORY DISTURBANCE 223 0.0139
343 ECCHYMOSIS 95 0.0138
344 EXOSTOSIS 126 0.0138
345 MIGRAINE 1314 0.0138
346 SUBARACHNOID HAEMORRHAGE 140 0.0137
347 CHOLELITHIASIS 450 0.0137
348 MUSCLE TIGHTNESS 222 0.0137
349 RENAL CYST 108 0.0136
350 LUNG INFILTRATION 120 0.0136
351 VITAMIN D DECREASED 116 0.0136
352 SYNCOPE 1351 0.0135
353 SUPRAVENTRICULAR TACHYCARDIA 129 0.0135
354 ROAD TRAFFIC ACCIDENT 562 0.0134
355 SCHIZOPHRENIA 163 0.0134
356 ACUTE KIDNEY INJURY 2050 0.0134
357 CARDIOGENIC SHOCK 191 0.0133
358 SEIZURE 1537 0.0133
359 BREAST PAIN 141 0.0132
360 DRUG WITHDRAWAL SYNDROME 1158 0.0132
361 FALL 4377 0.0131
362 DYSURIA 484 0.0131
363 CAESAREAN SECTION 153 0.0131
364 LIVER FUNCTION TEST ABNORMAL 382 0.0131
365 LOW BIRTH WEIGHT BABY 104 0.0131
366 ASCITES 384 0.0130
367 HEAD INJURY 413 0.0130
368 MALNUTRITION 146 0.0130
369 PRODUCT SUBSTITUTION ISSUE 750 0.0130
370 NOCTURIA 158 0.0130
371 WRIST FRACTURE 156 0.0130
372 ANKLE FRACTURE 201 0.0130
373 FOOT FRACTURE 246 0.0130
374 BRAIN FOG 203 0.0129
375 SENSATION OF FOREIGN BODY 109 0.0129
376 NIGHT SWEATS 416 0.0129
377 HAIR COLOUR CHANGES 160 0.0128
378 DELIRIUM 445 0.0128
379 HYPOKINESIA 186 0.0128
380 SENSORY LOSS 103 0.0128
381 IRON DEFICIENCY ANAEMIA 118 0.0128
382 BACK INJURY 139 0.0128
383 CARPAL TUNNEL SYNDROME 179 0.0128
384 CARDIOTOXICITY 114 0.0128
385 TOOTH ABSCESS 130 0.0128
386 UTERINE LEIOMYOMA 93 0.0127
387 INJURY 894 0.0127
388 NEURALGIA 309 0.0127
389 ARTERIOSCLEROSIS 119 0.0126
390 HEPATOMEGALY 124 0.0126
391 RENAL FAILURE CHRONIC 97 0.0126
392 ROTATOR CUFF SYNDROME 162 0.0126
393 PHARMACEUTICAL PRODUCT COMPLAINT 327 0.0126
394 DYSPHONIA 736 0.0126
395 FEELING ABNORMAL 3015 0.0126
396 ANOREXIA 162 0.0126
397 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 111 0.0125
398 DIABETIC KETOACIDOSIS 301 0.0125
399 BLOOD SODIUM DECREASED 236 0.0125
400 IMPAIRED QUALITY OF LIFE 180 0.0125
401 HUNGER 174 0.0125
402 OSTEOARTHRITIS 527 0.0124
403 HYPOXIA 436 0.0124
404 DRY MOUTH 1003 0.0123
405 BLOOD CALCIUM DECREASED 139 0.0123
406 RENAL INJURY 367 0.0123
407 HAEMATURIA 423 0.0123
408 ANAL INCONTINENCE 111 0.0123
409 CHOLECYSTITIS 147 0.0123
410 IRRITABLE BOWEL SYNDROME 264 0.0123
411 ACIDOSIS 94 0.0123
412 SUBSTANCE ABUSE 100 0.0123
413 TROPONIN INCREASED 93 0.0122
414 MUSCULOSKELETAL STIFFNESS 1070 0.0122
415 CARDIOMYOPATHY 180 0.0122
416 SPINAL DISORDER 115 0.0121
417 COLD SWEAT 213 0.0121
418 HYPERGLYCAEMIA 440 0.0121
419 IMPAIRED WORK ABILITY 258 0.0121
420 INCREASED TENDENCY TO BRUISE 111 0.0121
421 RENAL TUBULAR NECROSIS 118 0.0120
422 ABASIA 297 0.0120
423 APHASIA 362 0.0120
424 HEMIPARESIS 203 0.0120
425 LEUKAEMIA 113 0.0120
426 BODY HEIGHT DECREASED 128 0.0120
427 POLYURIA 98 0.0120
428 MUSCLE SPASTICITY 147 0.0120
429 RETCHING 255 0.0119
430 GASTROENTERITIS 174 0.0119
431 BODY TEMPERATURE INCREASED 243 0.0119
432 OVARIAN CYST 119 0.0119
433 LOSS OF CONSCIOUSNESS 1525 0.0119
434 HYPOTONIA 118 0.0118
435 OESOPHAGITIS 129 0.0118
436 VERTIGO 719 0.0118
437 GAIT DISTURBANCE 2253 0.0118
438 PARAESTHESIA 1851 0.0118
439 IMPAIRED DRIVING ABILITY 133 0.0117
440 INTENTIONAL DRUG MISUSE 244 0.0117
441 HAIR TEXTURE ABNORMAL 156 0.0117
442 SEASONAL ALLERGY 165 0.0116
443 JOINT INJURY 249 0.0116
444 PHARYNGITIS STREPTOCOCCAL 126 0.0116
445 DEVELOPMENTAL DELAY 105 0.0116
446 EYE PAIN 655 0.0116
447 SCIATICA 185 0.0116
448 STATUS EPILEPTICUS 131 0.0116
449 EAR DISCOMFORT 119 0.0116
450 BLINDNESS 472 0.0116
451 TREATMENT NONCOMPLIANCE 627 0.0114
452 SWELLING FACE 745 0.0114
453 EXPOSURE DURING PREGNANCY 711 0.0114
454 POLLAKIURIA 477 0.0114
455 NECK PAIN 638 0.0114
456 EMPHYSEMA 115 0.0114
457 FRUSTRATION TOLERANCE DECREASED 92 0.0114
458 MOTOR DYSFUNCTION 116 0.0114
459 THIRST 203 0.0114
460 BONE DISORDER 206 0.0113
461 MADAROSIS 131 0.0113
462 HEART RATE IRREGULAR 255 0.0113
463 ENCEPHALOPATHY 277 0.0113
464 SPINAL COMPRESSION FRACTURE 93 0.0112
465 UPPER RESPIRATORY TRACT INFECTION 517 0.0112
466 BRONCHITIS 828 0.0112
467 VISION BLURRED 1535 0.0112
468 HYPOTENSION 2240 0.0112
469 JOINT DISLOCATION 118 0.0112
470 RENAL PAIN 118 0.0111
471 HAEMORRHOIDS 217 0.0111
472 PANCREATITIS ACUTE 249 0.0111
473 HYPERTENSION 2346 0.0111
474 DYSPNOEA EXERTIONAL 416 0.0110
475 TACHYPNOEA 150 0.0110
476 INFLUENZA LIKE ILLNESS 908 0.0110
477 CONTUSION 1062 0.0110
478 ATRIAL FLUTTER 88 0.0110
479 DYSSTASIA 322 0.0110
480 PULMONARY HYPERTENSION 229 0.0110
481 PANCREATITIS 580 0.0110
482 EAR PAIN 213 0.0109
483 PARAESTHESIA ORAL 158 0.0109
484 RENAL FAILURE 1452 0.0109
485 DYSPEPSIA 1072 0.0109
486 HAEMATOCRIT DECREASED 216 0.0109
487 FACIAL PAIN 97 0.0109
488 BACK DISORDER 176 0.0108
489 EJECTION FRACTION DECREASED 168 0.0108
490 DEFORMITY 101 0.0108
491 URINARY TRACT INFECTION 1843 0.0108
492 CIRCULATORY COLLAPSE 184 0.0108
493 PALPITATIONS 1264 0.0108
494 MULTIPLE SCLEROSIS 515 0.0108
495 CHEST PAIN 1992 0.0107
496 MUSCLE STRAIN 93 0.0107
497 MULTIPLE SCLEROSIS RELAPSE 736 0.0107
498 PHARYNGITIS 133 0.0107
499 LIGAMENT SPRAIN 106 0.0107
500 RESPIRATORY RATE INCREASED 95 0.0107
501 LACTIC ACIDOSIS 346 0.0107
502 HYPOAESTHESIA 1599 0.0107
503 HYPOAESTHESIA ORAL 161 0.0107
504 ACUTE RESPIRATORY FAILURE 205 0.0106
505 DIZZINESS 5310 0.0106
506 MATERNAL EXPOSURE DURING PREGNANCY 944 0.0106
507 HEPATOCELLULAR INJURY 150 0.0106
508 MOVEMENT DISORDER 339 0.0105
509 BLOOD CREATINE PHOSPHOKINASE INCREASED 303 0.0105
510 CHILLS 1232 0.0105
511 OSTEOPOROSIS 432 0.0105
512 BEDRIDDEN 138 0.0105
513 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 502 0.0104
514 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 545 0.0104
515 LOWER LIMB FRACTURE 200 0.0104
516 RESPIRATORY DISTRESS 287 0.0104
517 OSTEOMYELITIS 188 0.0104
518 WHITE BLOOD CELL COUNT INCREASED 398 0.0104
519 CYSTITIS 330 0.0104
520 HEADACHE 6492 0.0103
521 HYPOGLYCAEMIA 502 0.0103
522 SPINAL PAIN 121 0.0103
523 VOMITING 4846 0.0103
524 SUDDEN DEATH 109 0.0103
525 SINUS CONGESTION 139 0.0103
526 HYPOPHAGIA 263 0.0103
527 SINUSITIS 1054 0.0103
528 THERAPY CHANGE 101 0.0103
529 HEAVY MENSTRUAL BLEEDING 92 0.0102
530 PULMONARY OEDEMA 457 0.0102
531 GASTROINTESTINAL PAIN 112 0.0102
532 ACCIDENTAL OVERDOSE 372 0.0102
533 NEPHROLITHIASIS 465 0.0101
534 PULMONARY MASS 151 0.0101
535 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 172 0.0101
536 MUSCULAR WEAKNESS 1151 0.0101
537 ABDOMINAL PAIN 2356 0.0101
538 MYOCARDIAL ISCHAEMIA 115 0.0101
539 OVERDOSE 2177 0.0101
540 PELVIC PAIN 183 0.0101
541 CORONARY ARTERY DISEASE 305 0.0101
542 DECREASED APPETITE 2338 0.0101
543 SKIN LACERATION 109 0.0100
544 INTENTIONAL PRODUCT MISUSE 877 0.0100
545 FEELING HOT 614 0.0100
546 TOOTH INFECTION 132 0.0100
547 PARALYSIS 143 0.0100
548 TEMPERATURE INTOLERANCE 103 0.0100
549 NEPHROPATHY 93 0.0100
550 HAEMATOMA 258 0.0099
551 HYPOTHYROIDISM 318 0.0099
552 CONDITION AGGRAVATED 3023 0.0099
553 WEIGHT DECREASED 2775 0.0099
554 HYPOCALCAEMIA 188 0.0099
555 BLOOD PRESSURE INCREASED 1514 0.0099
556 NERVE INJURY 110 0.0099
557 KIDNEY INFECTION 194 0.0099
558 DYSMENORRHOEA 131 0.0099
559 BLADDER DISORDER 98 0.0099
560 PULMONARY EMBOLISM 935 0.0098
561 PRODUCTIVE COUGH 469 0.0098
562 TUBULOINTERSTITIAL NEPHRITIS 184 0.0098
563 SCAR 168 0.0098
564 UPPER GASTROINTESTINAL HAEMORRHAGE 165 0.0098
565 GASTROENTERITIS VIRAL 177 0.0098
566 IMMUNODEFICIENCY 146 0.0098
567 EPILEPSY 299 0.0098
568 DEEP VEIN THROMBOSIS 633 0.0097
569 PHARYNGEAL OEDEMA 149 0.0097
570 RENAL FAILURE ACUTE 411 0.0097
571 NASAL CONGESTION 569 0.0097
572 SMALL INTESTINAL OBSTRUCTION 119 0.0097
573 CYANOSIS 152 0.0097
574 HERNIA 186 0.0096
575 FATIGUE 7487 0.0096
576 ANGIOEDEMA 425 0.0096
577 ANGINA PECTORIS 275 0.0096
578 NAUSEA 7586 0.0096
579 HEART RATE INCREASED 949 0.0096
580 TRANSIENT ISCHAEMIC ATTACK 323 0.0096
581 CHROMATURIA 216 0.0096
582 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 525 0.0096
583 ELECTROLYTE IMBALANCE 111 0.0095
584 ARRHYTHMIA 451 0.0095
585 GASTRIC ULCER 181 0.0095
586 FEEDING DISORDER 193 0.0095
587 CHEST DISCOMFORT 974 0.0095
588 HYPOMAGNESAEMIA 132 0.0095
589 FOOT DEFORMITY 105 0.0095
590 THERAPEUTIC RESPONSE UNEXPECTED 425 0.0095
591 WEIGHT FLUCTUATION 99 0.0095
592 NERVOUS SYSTEM DISORDER 295 0.0094
593 CELLULITIS 476 0.0094
594 OBSTRUCTIVE AIRWAYS DISORDER 105 0.0094
595 PRURITUS GENERALISED 204 0.0094
596 ASTHENIA 3541 0.0094
597 PHARYNGEAL SWELLING 92 0.0094
598 BURSITIS 114 0.0094
599 SPUTUM DISCOLOURED 89 0.0094
600 ORAL PAIN 210 0.0094
601 MYALGIA 1594 0.0094
602 ABDOMINAL PAIN UPPER 1927 0.0094
603 TOOTHACHE 169 0.0093
604 SHOCK 214 0.0093
605 MUSCULOSKELETAL CHEST PAIN 144 0.0093
606 FEELING COLD 259 0.0093
607 MEDICATION ERROR 515 0.0093
608 MUSCLE SPASMS 1699 0.0092
609 OROPHARYNGEAL PAIN 855 0.0092
610 INTERNATIONAL NORMALISED RATIO INCREASED 263 0.0092
611 BLOOD ALKALINE PHOSPHATASE INCREASED 229 0.0092
612 INSURANCE ISSUE 141 0.0092
613 DEHYDRATION 1224 0.0092
614 BRAIN OEDEMA 115 0.0091
615 MASS 127 0.0091
616 UPPER LIMB FRACTURE 181 0.0091
617 THYROID DISORDER 140 0.0091
618 GINGIVAL BLEEDING 124 0.0091
619 BACK PAIN 2107 0.0091
620 OEDEMA PERIPHERAL 1105 0.0091
621 MUSCULOSKELETAL DISCOMFORT 156 0.0091
622 LIP SWELLING 301 0.0090
623 EAR INFECTION 240 0.0090
624 WRONG TECHNIQUE IN DRUG USAGE PROCESS 327 0.0090
625 TOOTH DISORDER 200 0.0090
626 PHOTOSENSITIVITY REACTION 148 0.0090
627 ACCIDENT 107 0.0090
628 AMENORRHOEA 157 0.0089
629 DERMATITIS CONTACT 101 0.0088
630 DYSPHAGIA 840 0.0088
631 MUSCULOSKELETAL PAIN 463 0.0088
632 MALAISE 3871 0.0088
633 SEPSIS 983 0.0088
634 CENTRAL NERVOUS SYSTEM LESION 121 0.0088
635 DISABILITY 174 0.0088
636 MYOCARDITIS 100 0.0087
637 SCRATCH 92 0.0087
638 ARTHRITIS 686 0.0087
639 ALANINE AMINOTRANSFERASE INCREASED 535 0.0087
640 CYST 108 0.0087
641 STAPHYLOCOCCAL INFECTION 287 0.0087
642 POST PROCEDURAL COMPLICATION 167 0.0087
643 RECTAL HAEMORRHAGE 373 0.0087
644 HEPATIC CIRRHOSIS 163 0.0087
645 BLOOD GLUCOSE FLUCTUATION 95 0.0087
646 THROAT TIGHTNESS 234 0.0086
647 SPINAL FRACTURE 173 0.0086
648 SPLENOMEGALY 101 0.0086
649 NO THERAPEUTIC RESPONSE 105 0.0086
650 MUSCLE ATROPHY 109 0.0086
651 PERIPHERAL COLDNESS 118 0.0086
652 PRODUCT ODOUR ABNORMAL 90 0.0086
653 CONSTIPATION 1873 0.0086
654 BLOOD PRESSURE FLUCTUATION 206 0.0086
655 INFLUENZA 957 0.0086
656 SINUS DISORDER 169 0.0085
657 LIMB DISCOMFORT 264 0.0085
658 BLOOD PRESSURE ABNORMAL 169 0.0085
659 CONTRAINDICATED PRODUCT ADMINISTERED 257 0.0085
660 THERAPY NON-RESPONDER 381 0.0085
661 LIMB INJURY 230 0.0085
662 JOINT STIFFNESS 222 0.0085
663 RESPIRATORY FAILURE 617 0.0085
664 BLOOD PRESSURE SYSTOLIC INCREASED 165 0.0085
665 CHOKING 165 0.0084
666 ABDOMINAL DISTENSION 882 0.0084
667 HOT FLUSH 636 0.0084
668 BLOOD IRON DECREASED 100 0.0084
669 ADRENAL INSUFFICIENCY 102 0.0084
670 OXYGEN SATURATION DECREASED 472 0.0084
671 DYSPNOEA 4748 0.0084
672 MOBILITY DECREASED 602 0.0084
673 LOCAL SWELLING 146 0.0084
674 PAIN IN JAW 237 0.0084
675 WHEEZING 496 0.0084
676 ULCER 133 0.0084
677 CHOLESTASIS 160 0.0083
678 EMOTIONAL DISTRESS 1007 0.0083
679 MOUTH ULCERATION 175 0.0083
680 INFUSION SITE PAIN 107 0.0083
681 COAGULOPATHY 138 0.0083
682 STEVENS-JOHNSON SYNDROME 184 0.0083
683 SKIN LESION 227 0.0083
684 PRODUCT PRESCRIBING ERROR 197 0.0083
685 LYMPHOCYTE COUNT DECREASED 146 0.0083
686 LEUKOPENIA 413 0.0082
687 PAIN 5065 0.0082
688 BLOOD PRESSURE DECREASED 545 0.0082
689 THERAPY CESSATION 421 0.0082
690 GAIT INABILITY 274 0.0082
691 FLUSHING 833 0.0082
692 FAECES DISCOLOURED 177 0.0082
693 COUGH 2287 0.0081
694 EYE SWELLING 303 0.0081
695 PAIN IN EXTREMITY 2397 0.0081
696 DISEASE RECURRENCE 386 0.0081
697 ACUTE MYOCARDIAL INFARCTION 239 0.0081
698 CARDIAC FAILURE CONGESTIVE 649 0.0081
699 LYMPHADENOPATHY 286 0.0081
700 DYSGEUSIA 600 0.0081
701 DIARRHOEA 5208 0.0081
702 INTENTIONAL DOSE OMISSION 230 0.0081
703 JAUNDICE 217 0.0081
704 ASPARTATE AMINOTRANSFERASE INCREASED 427 0.0080
705 ORAL CANDIDIASIS 105 0.0080
706 HEART RATE DECREASED 280 0.0080
707 DEAFNESS 208 0.0079
708 ARTHRALGIA 3306 0.0079
709 GLAUCOMA 153 0.0079
710 ABNORMAL WEIGHT GAIN 98 0.0079
711 HEPATIC CYTOLYSIS 101 0.0079
712 VAGINAL HAEMORRHAGE 342 0.0079
713 PULMONARY FIBROSIS 151 0.0079
714 SKIN ULCER 203 0.0078
715 MENORRHAGIA 154 0.0078
716 DRUG EFFECT DECREASED 422 0.0078
717 DRUG INTOLERANCE 755 0.0078
718 APHONIA 109 0.0078
719 HIP FRACTURE 251 0.0078
720 MULTIPLE ORGAN DYSFUNCTION SYNDROME 221 0.0078
721 SURGERY 457 0.0078
722 FLATULENCE 442 0.0078
723 SPINAL OPERATION 96 0.0078
724 MELAENA 171 0.0078
725 ASTHMA 872 0.0077
726 ORAL DISCOMFORT 107 0.0077
727 CANDIDA INFECTION 130 0.0077
728 DEMENTIA 215 0.0077
729 VIRAL INFECTION 256 0.0077
730 OEDEMA 417 0.0077
731 SWELLING 719 0.0077
732 QUALITY OF LIFE DECREASED 103 0.0077
733 BACTERIAL INFECTION 143 0.0077
734 CORONARY ARTERY OCCLUSION 105 0.0076
735 DRUG DISPENSING ERROR 117 0.0076
736 BRONCHOSPASM 109 0.0076
737 EPISTAXIS 571 0.0076
738 UNEVALUABLE EVENT 575 0.0076
739 PREGNANCY 152 0.0076
740 HAEMOPTYSIS 211 0.0076
741 ISCHAEMIC STROKE 135 0.0076
742 RHINORRHOEA 487 0.0075
743 MULTI-ORGAN FAILURE 130 0.0075
744 GASTRIC DISORDER 258 0.0075
745 CLOSTRIDIUM DIFFICILE INFECTION 164 0.0075
746 HEPATITIS 192 0.0075
747 TENDONITIS 116 0.0075
748 THROAT IRRITATION 336 0.0075
749 FREQUENT BOWEL MOVEMENTS 202 0.0075
750 ABORTION SPONTANEOUS 299 0.0075
751 PALLOR 203 0.0075
752 TENDON RUPTURE 92 0.0074
753 IMMUNE SYSTEM DISORDER 98 0.0074
754 BLOOD URINE PRESENT 141 0.0074
755 SKIN HAEMORRHAGE 110 0.0074
756 BLOOD UREA INCREASED 124 0.0074
757 RED BLOOD CELL COUNT DECREASED 211 0.0074
758 EOSINOPHILIA 129 0.0074
759 AGEUSIA 183 0.0073
760 METRORRHAGIA 125 0.0073
761 PERICARDIAL EFFUSION 169 0.0073
762 PNEUMONIA 2356 0.0073
763 ABDOMINAL PAIN LOWER 184 0.0073
764 SECRETION DISCHARGE 91 0.0073
765 PYREXIA 2513 0.0073
766 ABDOMINAL DISCOMFORT 1216 0.0072
767 PLEURAL EFFUSION 438 0.0072
768 HYPERSENSITIVITY 1334 0.0072
769 RASH PRURITIC 389 0.0072
770 INJECTION SITE INDURATION 93 0.0072
771 ARTHROPATHY 398 0.0072
772 PNEUMONITIS 194 0.0071
773 FACE OEDEMA 120 0.0071
774 SKIN FISSURES 139 0.0071
775 DERMATITIS 149 0.0071
776 VISUAL ACUITY REDUCED 236 0.0071
777 DISCOMFORT 433 0.0071
778 BURNING SENSATION 497 0.0071
779 LOCALISED INFECTION 171 0.0071
780 RESPIRATORY TRACT INFECTION 184 0.0071
781 MENSTRUATION IRREGULAR 189 0.0070
782 FUNGAL INFECTION 235 0.0070
783 RASH MACULAR 245 0.0070
784 PROCEDURAL PAIN 194 0.0070
785 DRUG DOSE OMISSION 1151 0.0070
786 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 119 0.0069
787 ALOPECIA 1363 0.0069
788 INTENTIONAL PRODUCT USE ISSUE 608 0.0069
789 HYPERKALAEMIA 243 0.0069
790 ANAEMIA 1319 0.0069
791 IMPAIRED HEALING 227 0.0069
792 COLITIS 262 0.0069
793 BONE PAIN 404 0.0069
794 DRUG PRESCRIBING ERROR 132 0.0069
795 GASTROINTESTINAL DISORDER 615 0.0069
796 RESPIRATORY TRACT CONGESTION 109 0.0069
797 SUBDURAL HAEMATOMA 98 0.0068
798 EYE DISORDER 225 0.0068
799 PNEUMOTHORAX 108 0.0068
800 ACUTE HEPATIC FAILURE 93 0.0068
801 COMPLICATION OF DEVICE REMOVAL 123 0.0068
802 TOOTH LOSS 141 0.0068
803 PRURITUS 2612 0.0068
804 FLUID RETENTION 345 0.0068
805 CATARACT 402 0.0067
806 SNEEZING 151 0.0067
807 INFLAMMATION 346 0.0067
808 FLUID OVERLOAD 97 0.0067
809 BLINDNESS UNILATERAL 94 0.0067
810 NEUROPATHY PERIPHERAL 633 0.0066
811 RHEUMATOID ARTHRITIS 752 0.0066
812 ERUCTATION 128 0.0066
813 LUNG DISORDER 324 0.0066
814 GLOSSODYNIA 148 0.0066
815 GAMMA-GLUTAMYLTRANSFERASE INCREASED 146 0.0066
816 PRODUCT DOSE OMISSION IN ERROR 186 0.0066
817 LIVER INJURY 161 0.0066
818 FEMUR FRACTURE 203 0.0065
819 HIP ARTHROPLASTY 100 0.0065
820 ILLNESS 672 0.0065
821 VISUAL IMPAIRMENT 807 0.0065
822 DIVERTICULITIS 180 0.0065
823 RESPIRATORY DISORDER 194 0.0065
824 WOUND 181 0.0065
825 CARDIAC DISORDER 605 0.0065
826 ABSCESS 103 0.0064
827 LOWER RESPIRATORY TRACT INFECTION 293 0.0064
828 PSORIATIC ARTHROPATHY 261 0.0064
829 NASOPHARYNGITIS 1183 0.0064
830 DRY EYE 319 0.0064
831 ECZEMA 334 0.0064
832 INTERSTITIAL LUNG DISEASE 308 0.0064
833 HAEMATOCHEZIA 351 0.0064
834 BLOOD CREATININE INCREASED 415 0.0063
835 SKIN DISCOLOURATION 292 0.0063
836 PRODUCT PHYSICAL ISSUE 128 0.0063
837 MULTIPLE FRACTURES 104 0.0063
838 INTESTINAL OBSTRUCTION 238 0.0063
839 HEPATIC ENZYME INCREASED 430 0.0063
840 DRUG INEFFECTIVE 8311 0.0063
841 MUSCULOSKELETAL DISORDER 120 0.0063
842 PRODUCT USE IN UNAPPROVED INDICATION 1551 0.0063
843 URTICARIA 1046 0.0062
844 INJECTION SITE HAEMATOMA 90 0.0062
845 CEREBRAL HAEMORRHAGE 222 0.0062
846 DRUG ADMINISTRATION ERROR 190 0.0062
847 COVID-19 1086 0.0062
848 KNEE ARTHROPLASTY 130 0.0062
849 PSORIASIS 805 0.0062
850 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 438 0.0062
851 COMPLICATION OF DEVICE INSERTION 122 0.0061
852 ORAL HERPES 119 0.0061
853 CEREBROVASCULAR ACCIDENT 1030 0.0061
854 GENERAL PHYSICAL HEALTH DETERIORATION 702 0.0061
855 HAEMOGLOBIN DECREASED 623 0.0061
856 THROMBOSIS 487 0.0060
857 BASAL CELL CARCINOMA 94 0.0060
858 TOXIC EPIDERMAL NECROLYSIS 91 0.0060
859 JOINT SWELLING 722 0.0060
860 RASH MACULO-PAPULAR 133 0.0060
861 OFF LABEL USE 5219 0.0060
862 ATRIAL FIBRILLATION 580 0.0059
863 ADVERSE DRUG REACTION 534 0.0059
864 GASTROINTESTINAL HAEMORRHAGE 496 0.0059
865 HEPATIC FAILURE 178 0.0059
866 PERIPHERAL SWELLING 909 0.0059
867 WHITE BLOOD CELL COUNT DECREASED 639 0.0059
868 SKIN DISORDER 196 0.0059
869 CONJUNCTIVITIS 109 0.0059
870 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 417 0.0059
871 PRODUCT DOSE OMISSION 382 0.0058
872 STOMATITIS 353 0.0058
873 TASTE DISORDER 118 0.0058
874 RENAL DISORDER 271 0.0058
875 GOUT 104 0.0058
876 PAIN OF SKIN 156 0.0058
877 THERAPEUTIC RESPONSE DECREASED 351 0.0058
878 INJECTION SITE MASS 214 0.0058
879 DERMATITIS ATOPIC 305 0.0058
880 RASH PAPULAR 129 0.0057
881 PRESCRIBED UNDERDOSE 114 0.0057
882 TRANSAMINASES INCREASED 127 0.0057
883 DRUG EFFECT INCOMPLETE 206 0.0057
884 RASH ERYTHEMATOUS 270 0.0056
885 BLOOD GLUCOSE DECREASED 271 0.0056
886 RASH GENERALISED 146 0.0056
887 BLOOD GLUCOSE ABNORMAL 104 0.0056
888 BLOOD POTASSIUM INCREASED 91 0.0056
889 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 144 0.0056
890 SKIN EXFOLIATION 472 0.0056
891 C-REACTIVE PROTEIN INCREASED 202 0.0055
892 LIVER DISORDER 246 0.0055
893 BLISTER 310 0.0055
894 SEPTIC SHOCK 240 0.0055
895 MYOCARDIAL INFARCTION 959 0.0055
896 LABORATORY TEST ABNORMAL 162 0.0055
897 HERPES ZOSTER 315 0.0055
898 PRODUCT AVAILABILITY ISSUE 124 0.0054
899 RASH 2369 0.0054
900 INJECTION SITE PRURITUS 363 0.0054
901 GLYCOSYLATED HAEMOGLOBIN INCREASED 136 0.0054
902 ANAPHYLACTIC REACTION 296 0.0054
903 DRUG DEPENDENCE 860 0.0053
904 ILL-DEFINED DISORDER 323 0.0053
905 COLITIS ULCERATIVE 235 0.0053
906 BLOOD BILIRUBIN INCREASED 142 0.0053
907 PRODUCT ADMINISTRATION ERROR 106 0.0052
908 PRODUCT USE ISSUE 985 0.0052
909 THERAPEUTIC RESPONSE SHORTENED 173 0.0052
910 GYNAECOMASTIA 161 0.0052
911 LACRIMATION INCREASED 157 0.0052
912 INJECTION SITE REACTION 357 0.0052
913 HEPATOTOXICITY 115 0.0052
914 INFECTION 744 0.0051
915 OSTEONECROSIS OF JAW 127 0.0051
916 HYPOACUSIS 220 0.0051
917 PRODUCT DOSE OMISSION ISSUE 1501 0.0051
918 TREATMENT FAILURE 419 0.0051
919 RENAL IMPAIRMENT 422 0.0050
920 PRODUCT QUALITY ISSUE 682 0.0050
921 ERYTHEMA 1006 0.0049
922 DEVICE DISLOCATION 211 0.0048
923 DEVICE BREAKAGE 197 0.0048
924 UNDERDOSE 352 0.0048
925 CARDIOVASCULAR DISORDER 122 0.0048
926 AGRANULOCYTOSIS 89 0.0048
927 NEUTROPHIL COUNT DECREASED 194 0.0048
928 CARDIAC FAILURE 382 0.0048
929 BONE DENSITY DECREASED 149 0.0048
930 EYE PRURITUS 158 0.0047
931 DRUG-INDUCED LIVER INJURY 147 0.0047
932 EYE IRRITATION 269 0.0047
933 INJECTION SITE WARMTH 96 0.0047
934 THERAPY INTERRUPTED 331 0.0046
935 HAEMORRHAGE 483 0.0046
936 INJECTION SITE ERYTHEMA 573 0.0046
937 INJECTION SITE BRUISING 365 0.0046
938 BREAST CANCER FEMALE 122 0.0046
939 ADVERSE EVENT 416 0.0045
940 INFUSION RELATED REACTION 298 0.0045
941 BLOOD GLUCOSE INCREASED 842 0.0045
942 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 798 0.0044
943 THROMBOCYTOPENIA 495 0.0044
944 ANAPHYLACTIC SHOCK 114 0.0044
945 PANCYTOPENIA 247 0.0044
946 INJECTION SITE PAIN 1340 0.0044
947 DRY SKIN 583 0.0044
948 PRODUCT DISPENSING ERROR 95 0.0044
949 INJECTION SITE URTICARIA 107 0.0044
950 INCORRECT DRUG ADMINISTRATION DURATION 122 0.0043
951 SYSTEMIC LUPUS ERYTHEMATOSUS 149 0.0042
952 THERAPEUTIC PRODUCT EFFECT DECREASED 186 0.0041
953 NEUTROPENIA 564 0.0041
954 PRODUCT ADHESION ISSUE 148 0.0041
955 DRUG RESISTANCE 104 0.0040
956 INJECTION SITE SWELLING 310 0.0040
957 INJECTION SITE RASH 124 0.0040
958 INCORRECT DOSE ADMINISTERED 920 0.0040
959 PLATELET COUNT DECREASED 429 0.0040
960 OCULAR HYPERAEMIA 190 0.0040
961 APPLICATION SITE ERYTHEMA 102 0.0039
962 HOSPITALISATION 594 0.0039
963 ACNE 279 0.0037
964 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 745 0.0037
965 OSTEONECROSIS 120 0.0036
966 CEREBRAL INFARCTION 89 0.0036
967 NEEDLE ISSUE 104 0.0036
968 DEVICE EXPULSION 225 0.0035
969 INJECTION SITE HAEMORRHAGE 274 0.0034
970 DEVICE ISSUE 295 0.0033
971 SKIN IRRITATION 149 0.0032
972 DEVICE MALFUNCTION 227 0.0032
973 BREAST CANCER 298 0.0032
974 DISEASE PROGRESSION 362 0.0031
975 NEOPLASM MALIGNANT 202 0.0030
976 DEATH 2586 0.0030
977 HEPATIC FUNCTION ABNORMAL 112 0.0030
978 SKIN BURNING SENSATION 213 0.0030
979 EXPIRED PRODUCT ADMINISTERED 97 0.0029
980 DEPENDENCE 158 0.0029
981 EXTRA DOSE ADMINISTERED 113 0.0028
982 LUNG NEOPLASM MALIGNANT 112 0.0027
983 NEOPLASM PROGRESSION 92 0.0026
984 INCORRECT ROUTE OF DRUG ADMINISTRATION 93 0.0026
985 PLASMA CELL MYELOMA 101 0.0026
986 NO ADVERSE EVENT 450 0.0025
987 DEVICE LEAKAGE 107 0.0025
988 FEBRILE NEUTROPENIA 152 0.0023
989 ACCIDENTAL EXPOSURE TO PRODUCT 206 0.0020
990 MALIGNANT NEOPLASM PROGRESSION 199 0.0019
991 DRUG DOSE OMISSION BY DEVICE 106 0.0014
992 PRODUCT STORAGE ERROR 114 0.0013